The Legend Capital-backed endoscope provider has gone public on the Shanghai Stock Exchange’s Star market.
Aohua Endoscope, a China-based medical technology manufacturer backed by Legend Capital, the venture capital firm formed by conglomerate Legend Holdings, has floated in a RMB750m ($118m) initial public offering.
The company issued just over 33.3 million shares on the Shanghai Stock Exchange’s Star market priced at RMB22.5m each.
Founded in 1994, Aohua develops and produces endoscopes which are used to view the body internally, in methods of healthcare such as gastroenterology, pneumology and gynaecology.
Legend Capital provided roughly $16m in…
